Package 51316-210-02

Brand: naloxone hydrochloride

Generic: naloxone hydrochloride
NDC Package

Package Facts

Identity

Package NDC 51316-210-02
Digits Only 5131621002
Product NDC 51316-210
Product ID 51316-210_966798fe-b832-4179-ad41-664333d1872b
Description

2 VIAL in 1 CARTON (51316-210-02) / .1 mL in 1 VIAL (51316-210-01)

Marketing

Marketing Status
Marketed Since 2024-04-24
Brand naloxone hydrochloride
Generic naloxone hydrochloride
Sample Package No

Linked Drug Pages (1)

Naloxone Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["NASAL"], "spl_id": "966798fe-b832-4179-ad41-664333d1872b", "openfda": {"upc": ["0050428443958"], "unii": ["F850569PQR"], "rxcui": ["1725059"], "spl_set_id": ["840e017d-0142-4d0e-a80e-327ac44bc0c5"], "manufacturer_name": ["CVS Pharmacy, Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 VIAL in 1 CARTON (51316-210-02)  / .1 mL in 1 VIAL (51316-210-01)", "package_ndc": "51316-210-02", "marketing_start_date": "20240424"}], "brand_name": "Naloxone Hydrochloride", "product_id": "51316-210_966798fe-b832-4179-ad41-664333d1872b", "dosage_form": "SPRAY", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]"], "product_ndc": "51316-210", "generic_name": "Naloxone Hydrochloride", "labeler_name": "CVS Pharmacy, Inc", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Naloxone Hydrochloride", "active_ingredients": [{"name": "NALOXONE HYDROCHLORIDE", "strength": "4 mg/.1mL"}], "application_number": "ANDA217992", "marketing_category": "ANDA", "marketing_start_date": "20240424", "listing_expiration_date": "20261231"}